PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung
Duke University
Duke University
Regeneron Pharmaceuticals
Servier
The Netherlands Cancer Institute
EMD Serono
Regeneron Pharmaceuticals
Sensei Biotherapeutics, Inc.